Ronald Steis
Hematology & Oncology · Cumming, GANPI 1205875218
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,093 of the $1,318 with a category attached, or 82.9%. It is spread thinly across 20 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $724 and has fallen 94.7% since, to $38 in 2025. That places this record below the midpoint for hematology & oncology clinicians in GA, where the typical reported total is $4,479.
Across 65 payments — averaging $20.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$214
- AbbVie$178
- Novartis$166
- Merck$146
- Lilly USA, LLC$131
- Pfizer$118
- plus $366 from 14 others
Across 63 payments — averaging $11,172 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$610K
- E.r. Squibb & Sons, L.L.C.$50K
- Genentech, Inc.$44K
What the payments were for
- Food & beverage$1,09383%
- Education$22617%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 8 | $214 |
| AbbVie | 8 | $178 |
| Novartis | 3 | $166 |
| Merck | 9 | $146 |
| Lilly USA, LLC | 2 | $131 |
| Pfizer | 14 | $118 |
| Seagen Inc. | 4 | $59 |
| Foundation Medicine, Inc. | 1 | $49 |
| GSK | 2 | $38 |
| Astellas Pharma US Inc | 2 | $34 |
| Amgen | 2 | $32 |
| Johnson & Johnson | 2 | $29 |
| Mylan Institutional Inc. | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Dova Pharmaceuticals | 1 | $17 |
| Epizyme, Inc. | 1 | $17 |
| Sanofi | 1 | $16 |
| Bristol Myers Squibb | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,318 in reported general payments places this provider in the 30th percentile of 370 hematology & oncology providers in Georgia.
Other hematology & oncology in Cumming
- Amelia ZelnakCumming$31K
- Priya RudolphAthens$745K
- Aron KefelaHiram$591K
- Chandar BhimaniConyers$483K
- Ticiana LealAtlanta$450K
- Steven McCuneMarietta$450K
- Jorge LeguizamoLawrenceville$409K
- Trevor FeinsteinFayetteville$341K
- Jigarkumar ParikhAugusta$267K
- Ajay NookaAtlanta$222K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.